Citation Tools

PDF

Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System

Download to a citation manager

Cite this article as:
Fadini GP, Sarangdhar M, Avogaro A
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System